🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

9550+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9550 recruiting trials

NARecruitingNCT07413835

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

👨‍⚕️ Guiyun Cui, The Affiliated Hospital of Xuzhou Medical University📍 1 site📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07387471

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

👨‍⚕️ ABBVIE INC., AbbVie📍 3 sites📅 Started Mar 2026View details ↗
NARecruitingNCT07402226

Systemic Sclerosis DIet for GastrointESTinal Symptoms

👨‍⚕️ Dinesh Khanna, MD, MSc, University of Michigan📍 1 site📅 Started Mar 2026View details ↗
RecruitingNCT06725173

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

👨‍⚕️ Debarshi Mustafi, MD PhD, University of Washington📍 1 site📅 Started Mar 2026View details ↗
NARecruitingNCT07283081

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

👨‍⚕️ Marie-Elise TRUCHETET, MD, PhD, University Hospital, Bordeaux📍 1 site📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07010497

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

🏥 Asan Medical Center📍 1 site📅 Started Mar 2026View details ↗
NARecruitingNCT06907095

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

👨‍⚕️ Suzette Delaloge, MD, Gustave Roussy, Veillejuif, France📍 1 site📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT07291076

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 45 sites📅 Started Mar 2026View details ↗
NARecruitingNCT05917210

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

👨‍⚕️ J. Lucian Davis, MD, MAS, Yale University📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07500090

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

👨‍⚕️ David Seiden, MD, Harmony Biosciences Management, Inc.📍 12 sites📅 Started Mar 2026View details ↗
NARecruitingNCT07446959

Minimum Effective Volume of Bupivacaine for Serratus Posterior Superior Intercostal Plane Block in Video-Assisted Thoracoscopic Surgery

🏥 Bursa City Hospital📍 1 site📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT07270770

BY002 IIT Study in R/R Acute Leukemia

👨‍⚕️ Suning Chen, MD, PhD, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT06410001

CE-STAND: Cervical Epidural STimulation After Neurologic Damage

👨‍⚕️ Ann Parr, MD, PhD, University of Minnesota📍 1 site📅 Started Mar 2026View details ↗
NARecruitingNCT07488338

HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness

🏥 Teachers College, Columbia University📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07220785

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 1 site📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT06863311

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

👨‍⚕️ Karie Runcie, MD, Columbia University📍 2 sites📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07457528

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07362979

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

🏥 Sun Yat-sen University📍 4 sites📅 Started Mar 2026View details ↗
NARecruitingNCT07470151

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

👨‍⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT07089121

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

🏥 Cartesian Therapeutics📍 2 sites📅 Started Mar 2026View details ↗
← PreviousPage 5 of 478Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →